The pancreatic cancer secretome activates the STAT3 signaling in pancreatic stellate cells to drive the secretion of muscle atrophy-inducing factors
Abstract The pancreatic tumor microenvironment, a major component of pancreatic tumors, plays important roles in tumor progression, metastasis, and chemotherapy resistance. In patients with advanced pancreatic cancer, unintentional weight loss by muscle and/or adipose tissue atrophy, called cancer cachexia, is frequently observed. Although it is well established that cancer cells secrete muscle atrophy-inducing factors, we investigated whether cancer cells also produce factors to facilitate the ability of microenvironmental cells to confer an atrophic phenotype. To test this possibility, pancreatic stellate cells were treated with conditioned medium (CCM) from various pancreatic cancer cells. We revealed that CCM from cancer cells consistently activated STAT3 to induce an atrophic phenotype in stellate cells and that this induction was not observed when CCM from brefeldin A (BFA)-treated cancer cells was added. These results suggest that conventionally secreted factors from cancer cells are responsible for the acquisition of an atrophic phenotype in stellate cells. On the other hand, BFA did not inhibit the secretion of muscle atrophy-inducing factors from either pancreatic cancer cells or stimulated stellate cells. We therefore propose that not only conventionally, but also unconventionally secreted factors contribute to muscle atrophy.
Authors
- Guoxiang Zhang (ORCID: https://orcid.org/0000-0002-1031-149X)
- Takahiro Yamakawa (ORCID: https://orcid.org/0000-0001-5697-1349)
- Liza Bengrine Najjar
- Keiichi Itakura
Institutions
- Beckman Research Institute (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41598-026-80206-9
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Genentech